3 Pot Stocks Poised for Epic Growth

When you invest in The Green Organic Dutchman Holdings Ltd. (TSX:TGOD), The Flowr Corp. (TSXV:FLWR) or Auxly Cannabis Group Inc. (TSXV:XLY), be patient. All three companies will soon deliver monumental returns.

| More on:

The legalization of adult-use marijuana in Canada is almost one-year-old. Will pot stocks ever deliver sky-high returns? Believe it or not, The Green Organic Dutchman (TSX:TGOD), Flowr (TSXV:FLWR), and Auxly (TSXV:XLY) will carry the torch for the industry. All three pot stocks are poised for epic growth.

Purely organic

TGOD was built on the concept of entirely organic processes. All of its products are free of synthetic pesticides and fertilizers. Led by CEO Brian Athaide, the company will make sure TGOD would be able to provide organic cannabis on an international scale.

Athaide brings with him more than 28 years of global executive experience. Before joining TGOD, Athaide held top-level positions at Andrew Peller and Proctor & Gamble.

With a projected peak annual production of 219,000 kilograms, TGOD would be one of Canada’s top five cannabis producers. Once the facilities are fully operational, its $39.1 million sales in 2019 could surge to $227.9 million, or a monstrous 482.9% increase.

TGOD’s flagship Valleyfield campus will concentrate on beverage and edible production. A three-year agreement with extraction services provider Neptune Wellness Solutions is in place.

TGOD can ramp up commercial production of high-margin derivative products from 200,000 plus kilos of cannabis and hemp biomass. TGOD would finally taste profitability for the first time in 2020.

Blossoming flower

Flowr is not a significant cannabis grower, but the small-cap stock offers tremendous growth opportunities. Its flagship Kelowna facility, one of the most advanced, purpose-built cultivation facilities in the world, could produce a minimum of 50,000 kilos at peak capacity.

With its niche play on dried flowers (premium and ultra-premium) and derivatives, the company won’t be dealing with pricing or supply issues. Sales in 2019 could potentially skyrocket by 354.8% to $104.6 million in 2020.

Flowr’s seven million square feet grow farm in Portugal would create derivative products for Europe’s medical market. Once fully operational, the outdoor growing facility could produce half-a-million kilos of marijuana.

But the Kelowna campus is Flowr’s most significant advantage. The facility could grow varieties of top quality cannabis cycle after cycle and with consistency.

Cheapest but astonishing potential

You can buy Auxly for less than $1 today, but don’t underestimate this $554.95 million integrated cannabis company. Your investment could grow by 3,077.5% in a year.

A team composed of visionaries with in-depth industry knowledge formed Auxly in 2017. The members possess the scientific and technical expertise to bring branded and high-quality cannabis products to the medical, wellness and adult-use markets.

Auxly could be the fastest-growing cannabis stock because of several streaming partnerships and the joint venture with Sunens Farms. Sunens is a fully automated, purpose-built greenhouse that’s currently under construction. Bank of Montreal is providing a $71.5 syndicated credit facility.

The one million square feet greenhouse can cultivate 100,000 kilograms of cannabis yearly beginning the second quarter of 2020. Auxly earned a paltry $5.8 million in 2019 because the joint venture and the partnerships have yet to obtain the cultivation licenses.

By next year, however, you can expect Auxly’s sales to balloon to $184.3 million. The company is holding back dried flower production. The plan is to transform this low-margin product into high-margin derivatives (concentrates, edibles, and vapes) and make them the future growth drivers.

Not dead in the water

The cannabis industry is not dead in the water. The three small-cap pot stocks would prove critics wrong with epic growth in 2020 and beyond.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool is short shares of Procter & Gamble.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »